2014 MPN Challenge Michael Deininger

Michael Deininger, Huntsman Cancer Institute / Department of Hematology and Hematologic Malignancies, University of Utah School of Medicine

Michael Deininger MPN ResearcherProject Title

Engineering CAR T Cells That Target Mutant CALR as a Novel Therapeutic for Myeloproliferative Neoplasms

Focus Area(s)

CALR Mutation; Immunotherapy

Brief Description

This researcher aims to create an antibody that targets the CALR mutation in the hopes of creating a new treatment for CALR mutant derived MPN. Recently, a treatment was developed for Chronic Lymphocytic Leukemia (CLL). In clinical trials this targeting successfully killed the cells that caused CLL. The hope is to develop something similar for MPN.

Subscribe to updates to learn more about available MPN treatments.

James

Myelofibrosis (MF)

Meet James

Take the steps you need to help change your prognosis.

x

NEVER MISS AN UPDATE

Get free, timely information on living with an MPN.

Subscribe